Hofseth BioCare ASA Logo

Hofseth BioCare ASA

ISIN

NO0010598683

Ticker

HBC

Sector

Consumer Staples

Sub-Industry

Agricultural Products & Services

Country

Norway

Year Founded

2000

About Hofseth BioCare ASA

Company Description

Our mission is to explore the medical and pharmaceutical potential in compounds from our products, derived from an innovative hydrolysis technology. In the years to come we are confident – and research from some of the world leading university and hospitals clearly indicates – that our technology could become the basis of tomorrow's medicine.

In addition to the potential in becoming the medicine of tomorrow, HBC has an established industry that develops high-value ingredients and finished products for the nutrition market. Our products are present in 40 different countries throughout the world.

The company is founded on the core values of sustainability, traceability and optimal utilization of natural resources.

Hofseth BioCare's headquarters are in Ålesund, Norway with branches in Oslo, Chicago, Mumbai, Tokyo and Menlo Park, California.

Served Area

Worldwide

Headquarters

Kipervikgata 13
6003, Ålesund
Norway

Financial statements

Download as Excel
Line item in (nok) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Assets N/A 459,134,000.00 415,973,000.00 411,030,000.00
Noncurrent Assets N/A 187,664,000.00 245,662,000.00 235,282,000.00
Fixtures And Fittings N/A 847,000.00 2,281,000.00 2,592,000.00
Intangible Assets Other Than Goodwill N/A 42,434,000.00 53,055,000.00 60,588,000.00
Copyrights Patents And Other Industrial Property Rights Service And Operating Rights N/A 42,434,000.00 53,055,000.00 N/A
Investments In Associates Accounted For Using Equity Method N/A 5,733,000.00 5,764,000.00 5,559,000.00
Investments In Subsidiaries N/A 0.00 0.00 0.00
Other Noncurrent Financial Assets N/A 1,542,000.00 1,012,000.00 340,000.00
Current Assets N/A 271,470,000.00 170,311,000.00 175,748,000.00
Inventories N/A 73,302,000.00 90,813,000.00 116,525,000.00
Current Trade Receivables N/A 14,267,000.00 10,089,000.00 14,072,000.00
Other Current Receivables N/A 11,066,000.00 19,488,000.00 12,724,000.00
Cash and cash equivalents 94,553,000.00 172,835,000.00 49,921,000.00 32,427,000.00
Equity And Liabilities N/A 459,134,000.00 415,973,000.00 411,030,000.00
Equity 117,749,000.00 263,764,000.00 140,378,000.00 148,030,000.00
Issued Capital N/A 3,578,000.00 3,578,000.00 3,951,000.00
Share Premium N/A 236,709,000.00 137,485,000.00 144,765,000.00
Additional Paidin Capital N/A 8,684,000.00 0.00 0.00
Noncontrolling Interests N/A -684,000.00 -685,000.00 -686,000.00
Liabilities N/A 195,370,000.00 275,595,000.00 263,000,000.00
Noncurrent Liabilities N/A 89,191,000.00 124,662,000.00 90,772,000.00
Longterm Borrowings N/A 3,768,000.00 1,352,000.00 812,000.00
Current Liabilities N/A 106,179,000.00 150,933,000.00 172,228,000.00
Trade And Other Current Payables To Trade Suppliers N/A 84,956,000.00 124,165,000.00 145,752,000.00
Other Current Liabilities N/A 9,571,000.00 12,249,000.00 13,081,000.00
Line item in (nok) 01.01.2020/
01.01.2021
01.01.2021/
01.01.2022
01.01.2022/
01.01.2023
Revenue From Contracts With Customers 52,514,000.00 76,878,000.00 119,128,000.00
Other Income 16,738,000.00 10,738,000.00 1,320,000.00
Raw Materials And Consumables Used 39,532,000.00 64,517,000.00 91,934,000.00
Employee Benefits Expense 42,641,000.00 44,713,000.00 57,043,000.00
Depreciation Amortisation And Impairment Loss Reversal Of Impairment Loss Recognised In Profit Or Loss 26,766,000.00 29,350,000.00 30,412,000.00
Other Expense By Nature 52,334,000.00 67,600,000.00 69,677,000.00
Profit Loss From Operating Activities -92,021,000.00 -118,565,000.00 -128,618,000.00
Finance Income 3,364,000.00 3,647,000.00 4,568,000.00
Finance Costs 12,650,000.00 11,577,000.00 13,136,000.00
Profit Loss Before Tax -102,091,000.00 -126,464,000.00 -137,390,000.00
Income Tax Expense Continuing Operations 0.00 0.00 0.00
Profit (loss) -102,091,000.00 -126,464,000.00 -137,390,000.00
Line item in (nok) 01.01.2020 01.01.2021 01.01.2022 01.01.2023
Profit (loss) N/A -102,091,000.00 -126,464,000.00 -137,390,000.00
Adjustments For Decrease Increase In Inventories N/A -39,315,000.00 -17,511,000.00 -25,712,000.00
Adjustments For Increase Decrease In Trade Account Payable N/A 55,245,000.00 39,208,000.00 70,355,000.00
Adjustments For Undistributed Profits Of Associates N/A -784,000.00 31,000.00 204,000.00
Income Taxes Paid Refund Classified As Operating Activities N/A 0.00 0.00 0.00
Cash Flows From Used In Operating Activities N/A -61,632,000.00 -61,779,000.00 -45,168,000.00
Other Cash Payments To Acquire Equity Or Debt Instruments Of Other Entities Classified As Investing Activities N/A 6,517,000.00 188,000.00 0.00
Purchase Of Property Plant And Equipment Classified As Investing Activities N/A 32,575,000.00 22,924,000.00 4,020,000.00
Purchase Of Intangible Assets Classified As Investing Activities N/A 21,882,000.00 14,827,000.00 13,758,000.00
Proceeds From Other Longterm Assets Classified As Investing Activities N/A 918,000.00 0.00 N/A
Cash Flows From Used In Investing Activities N/A -60,056,000.00 -37,939,000.00 -17,778,000.00
Proceeds From Issuing Shares N/A 245,645,000.00 0.00 70,777,000.00
Proceeds From Borrowings Classified As Financing Activities N/A 39,021,000.00 1,087,000.00 0.00
Repayments Of Borrowings Classified As Financing Activities N/A 60,974,000.00 3,421,000.00 2,420,000.00
Payments Of Lease Liabilities Classified As Financing Activities N/A 9,666,000.00 11,469,000.00 12,625,000.00
Cash Flows From Used In Financing Activities N/A 199,970,000.00 -23,197,000.00 45,452,000.00
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes N/A 78,282,000.00 -122,914,000.00 -17,494,000.00
Cash and cash equivalents 94,553,000.00 172,835,000.00 49,921,000.00 32,427,000.00

Please note that some sums might not add up.

Filings & Publications

  • Consolidated Report 2022 - Q4 English 🇬🇧 Published: 09.05.2023
  • Consolidated Report 2021 - Q4 Norwegian 🇳🇴

Capital Markets Information

ISIN

NO0010598683

LEI

5967007LIEEXZXGGEO44

Listed Stock Exchange

Oslo Børs

Contact Investor Relations department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.